Lawton Alison Frances

CIK 00015426508 companiesLEXINGTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001542650

Recent Transactions

50 trades

Award
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2025-05-22+12,500→ 12,500 total
Award
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2024-06-10+45,000→ 96,667 total
Award
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2024-05-23+11,000→ 11,000 total
Award
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2023-09-11+6,500→ 6,500 total
Award
Spyre Therapeutics, Inc.$SYRE
Stock Option (right to buy)
2023-06-22+1,950,000→ 1,950,000 total
Award
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2023-06-13+45,000→ 51,667 total
Award
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2022-06-28+20,000→ 20,000 total
Award
Spyre Therapeutics, Inc.$SYRE
Director Stock Option (right to buy)
2022-06-07+43,000→ 43,000 total
Award
X4 Pharmaceuticals, Inc$XFOR
Common Stock
2022-06-06+6,667→ 6,667 total
Award
Spyre Therapeutics, Inc.$SYRE
Director Stock Option (right to buy)
2021-06-08+40,000→ 40,000 total
Award
X4 Pharmaceuticals, Inc$XFOR
Stock Option (right to buy)
2021-06-02$9.50/sh+6,000→ 6,000 total
Award
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2021-06-01+18,188→ 18,188 total
Award
Dianthus Therapeutics, Inc. /DE/$DNTH
Stock Option (Right to Buy)
2020-12-22+36,377→ 36,377 total
Award
Spyre Therapeutics, Inc.$SYRE
Director Stock Option (right to buy)
2020-12-15+47,200→ 47,200 total
Award
X4 Pharmaceuticals, Inc$XFOR
Stock Option (right to buy)
2020-10-05+6,854→ 6,854 total
Award
Kaleido Biosciences, Inc.
Stock Option (Right to Buy)
2020-04-15+118,500→ 118,500 total
Award
Kaleido Biosciences, Inc.
Restricted Stock Units
2020-02-28+46,325→ 46,325 total
Award
Kaleido Biosciences, Inc.
Stock Option (Right to Buy)
2019-11-15−150,000→ 150,000 total
Award
Verastem, Inc.$VSTM
Stock Option (Right to Buy)
2019-06-21+25,000→ 25,000 total
Award
Kaleido Biosciences, Inc.
Stock Option (Right to Buy)
2019-03-04+150,000→ 150,000 total
Award
Verastem, Inc.$VSTM
Stock Option (Right to Buy)
2018-06-11+25,000→ 25,000 total
Award
Verastem, Inc.$VSTM
Stock Option (Right to Buy)
2017-06-13+25,000→ 25,000 total
Disposition to Issuer
CoLucid Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2017-03-01$10.30/sh−658→ 0 total
Disposition to Issuer
CoLucid Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2017-03-01$39.96/sh−1,420→ 0 total
Disposition to Issuer
CoLucid Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2017-03-01$40.26/sh−8,897→ 0 total
Award
CoLucid Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2017-01-03$30.40/sh+658→ 658 total
Award
Verastem, Inc.$VSTM
Stock Option (Right to Buy)
2016-06-14+25,000→ 25,000 total
Award
CoLucid Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2016-05-10+8,897→ 8,897 total
Award
CoLucid Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2016-03-11+1,420→ 1,420 total
Award
Verastem, Inc.$VSTM
Stock Option (Right to Buy)
2015-06-12+17,969→ 17,969 total
Disposition to Issuer
CUBIST PHARMACEUTICALS INC
Stock Options (Right to Buy)
2015-01-21−8,370→ 0 total
Disposition to Issuer
CUBIST PHARMACEUTICALS INC
Stock Options (Right to Buy)
2015-01-21−10,842→ 0 total
Disposition to Issuer
CUBIST PHARMACEUTICALS INC
Restricted Stock Units
2015-01-21−1,687→ 0 total
Disposition to Issuer
CUBIST PHARMACEUTICALS INC
Stock Options (Right to Buy)
2015-01-21−6,202→ 0 total
Other
CUBIST PHARMACEUTICALS INC
Common Stock
2015-01-21$102.00/sh−4,717→ 0 total
Disposition to Issuer
CUBIST PHARMACEUTICALS INC
Stock Options (Right to Buy)
2015-01-21−9,367→ 0 total
Purchase
Verastem, Inc.$VSTM
Common Stock
2014-11-11$9.17/sh+2,500→ 2,500 total
Award
CUBIST PHARMACEUTICALS INC
Common Stock
2013-06-12+995→ 2,714 total
Award
CUBIST PHARMACEUTICALS INC
Stock Options (Right to Buy)
2013-06-12+8,370→ 8,370 total
Award
CUBIST PHARMACEUTICALS INC
Restricted Stock Units
2013-06-12+1,104→ 1,104 total
Award
Tempest Therapeutics, Inc.$TPST
Stock Option (right to buy)
2013-06-07+100,300→ 100,300 total
Exercise/Conversion
CUBIST PHARMACEUTICALS INC
Restricted Stock Units
2013-06-06−1,347→ 0 total
Exercise/Conversion
CUBIST PHARMACEUTICALS INC
Common Stock
2013-06-06+1,347→ 1,719 total
Award
Verastem, Inc.$VSTM
Stock Option (Right to Buy)
2013-06-04+6,507→ 6,507 total
Award
Verastem, Inc.$VSTM
Stock Option (Right to Buy)
2013-06-04+12,500→ 12,500 total
Award
Tempest Therapeutics, Inc.$TPST
Stock Option (right to buy)
2013-03-07+368,892→ 368,892 total
Award
Verastem, Inc.$VSTM
Stock Option (Right to Buy)
2012-11-26+25,000→ 25,000 total
Award
CUBIST PHARMACEUTICALS INC
Stock Options (Right to Buy)
2012-06-06+9,367→ 9,367 total
Award
CUBIST PHARMACEUTICALS INC
Restricted Stock Units
2012-06-06+1,347→ 1,347 total
Award
CUBIST PHARMACEUTICALS INC
Common Stock
2012-06-06+372→ 372 total

Companies

Address

65 HAYDEN AVENUE

LEXINGTON, MA, 02421

View on SEC.gov

Lawton Alison Frances

Recent Transactions

Companies

Recent Filings

Address